Viewing Study NCT05168904


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2025-12-28 @ 11:08 AM
Study NCT ID: NCT05168904
Status: SUSPENDED
Last Update Posted: 2024-02-08
First Post: 2021-12-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
Sponsor: Cyclacel Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module